Raymond James & Associates’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17,122
Closed -$603K 3926
2023
Q1
$603K Buy
17,122
+498
+3% +$18K ﹤0.01% 2806
2022
Q4
$564K Sell
16,624
-11,333
-41% -$384K ﹤0.01% 2816
2022
Q3
$912K Buy
27,957
+5,887
+27% +$218K ﹤0.01% 2462
2022
Q2
$750K Buy
22,070
+4,322
+24% +$181K ﹤0.01% 2641
2022
Q1
$1.04M Buy
17,748
+5,183
+41% +$316K ﹤0.01% 2571
2021
Q4
$947K Buy
+12,565
New +$804K ﹤0.01% 2645
2021
Q3
Sell
-11,838
Closed -$503K 4207
2021
Q2
$503K Buy
+11,838
New +$441K ﹤0.01% 3080
2018
Q3
Sell
-112,605
Closed -$1.76M 3690
2018
Q2
$1.76M Buy
+112,605
New +$2.27M ﹤0.01% 1839
2018
Q1
Sell
-129,870
Closed -$3.43M 3541
2017
Q4
$3.43M Buy
129,870
+86,237
+198% +$2.15M 0.01% 1345
2017
Q3
$1.04M Sell
43,633
-32,149
-42% -$773K ﹤0.01% 2072
2017
Q2
$2.11M Buy
75,782
+6,060
+9% +$177K ﹤0.01% 1538
2017
Q1
$1.96M Sell
69,722
-4,281
-6% -$110K ﹤0.01% 1547
2016
Q4
$1.61M Buy
74,003
+19,663
+36% +$407K ﹤0.01% 1624
2016
Q3
$1.1M Buy
54,340
+37,261
+218% +$732K ﹤0.01% 1829
2016
Q2
$307K Sell
17,079
-473
-3% -$8.78K ﹤0.01% 2401
2016
Q1
$325K Buy
+17,552
New +$278K ﹤0.01% 2281

Other funds holding MXL

Raymond James & Associates's MXL Position: Q2 2023 in Review

Raymond James & Associates sold out of MaxLinear (MXL) in Q2 2023, closing a stake of 17,122 shares — an estimated $603K sold.

Raymond James & Associates first reported a position in MXL in Q1 2016 and held it in 16 quarters. The position peaked at $3.43M in Q4 2017. 250 funds tracked by Wall St. Rank hold MXL as of Q2 2023.

  • Raymond James & Associates reported no remaining MaxLinear position as of Q2 2023 after selling out during the quarter.
  • Raymond James & Associates sold 17,122 MaxLinear shares in Q2 2023, an estimated $603K.
  • Raymond James & Associates first reported a position in MaxLinear in Q1 2016 and held it in 16 quarters.
  • Raymond James & Associates's MaxLinear position peaked at $3.43M in Q4 2017.
  • 250 funds tracked by Wall St. Rank held MaxLinear as of Q2 2023.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.